A detailed history of Martin Capital Advisors, LLP transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Martin Capital Advisors, LLP holds 11,679 shares of LNTH stock, worth $1.05 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
11,679
Previous 11,679 -0.0%
Holding current value
$1.05 Million
Previous $937,000 36.71%
% of portfolio
0.91%
Previous 0.7%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$55.6 - $77.89 $14,845 - $20,796
267 Added 2.34%
11,679 $724,000
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $18,954 - $22,919
230 Added 2.06%
11,412 $957,000
Q1 2022

May 05, 2022

SELL
$24.28 - $56.64 $80,221 - $187,138
-3,304 Reduced 22.81%
11,182 $618,000
Q4 2021

Feb 08, 2022

BUY
$22.54 - $30.44 $326,514 - $440,953
14,486 New
14,486 $419,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.21B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Martin Capital Advisors, LLP Portfolio

Follow Martin Capital Advisors, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Capital Advisors, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Martin Capital Advisors, LLP with notifications on news.